Fig. 4From: Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trialsContent validation: impact on HRQoL domains reported by patients. HRQoL health-related quality of lifeBack to article page